4.1638
price down icon2.46%   -0.1062
 
loading

Finanzdaten der Savara Inc-Aktie (SVRA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
8.79%
28.43
31.17 26.36 23.19 22.48
Depreciation and Amortization
6.25%
0.03
0.032 0.033 0.033 0.032
Operating Income/Loss
8.79%
-28.43
-31.17 -26.36 -23.19 -22.48
Income/Loss From Continuing Operations Before Tax
8.28%
-26.64
-29.04 -24.25 -22.24 -20.35
Income/Loss From Continuing Operations After Tax
8.31%
-26.64
-29.05 -24.25 -22.24 -20.35
Net Income/Loss
8.28%
-26.64
-29.04 -24.25 -22.24 -20.35
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
3,631%
216.15
5.7934 211.85 182.58 182.55
Diluted Average Shares
3,631%
216.15
5.7934 211.85 182.58 182.55
Basic Earnings Per Share
7.69%
-0.12
-0.13 -0.11 -0.12 -0.11
Diluted Earnings Per Share
7.69%
-0.12
-0.13 -0.11 -0.12 -0.11
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$37.70
price up icon 1.11%
$28.91
price up icon 0.79%
$102.30
price up icon 0.64%
$104.01
price up icon 0.05%
biotechnology ONC
$310.12
price down icon 0.56%
$183.72
price down icon 1.36%
Kapitalisierung:     |  Volumen (24h):